[ASAP] Correction to “Codelivery of TRAIL and Mitomycin C via Liposomes Shows Improved Antitumor Effect on TRAIL-Resistant Tumors” 🔗 Access full article via ACS Molecular PharmaceuticsMolecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.5c00112 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon